Halcones Precious Metals to Raise up to CA$1 Million Via Non-Brokered Private Placement

MT newswire2026/10/09 11:35

07:35 AM EDT, 10/09/2026 (MT Newswires) -- Halcones Precious Metals (HPM.V) plans to raise gross proceeds of up to CA$1 million through a non-brokered private placement financing of up to 20 million units to be priced at CA$0.05 each, it said after markets closed Thursday. Each unit will be made up of a share and a two-year warrant, with each warrant entitling the holder to buy a share at an exercise price of CA$0.05 per share, said the company. The company plans to use the net proceeds to obtain the surface rights to the Polaris project, continue the exploration work on its Polaris project as well as for general corporate working capital purposes, it said. The offering, scheduled to close on or about Oct. 15, is subject to approval of the TSX Venture Exchange, it added.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12